NanoViricides is trading 10.5% lower at $1.37 following a sharp drop from its July 23 close of $1.53, despite a lack of fresh company-specific news, earnings, or regulatory updates.
- The decline occurs against a modestly positive broader market backdrop, suggesting the move is driven by stock-specific trading dynamics rather than sector or macro headlines.
- No material corporate developments or filings have been identified to account for the sudden price volatility.